Nuzenio

Lrmr

Lrmr news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 10 publisher sources 100/100 entity strength

Latest news

LRMR Feb 2027 7.500 call (LRMR270219C00007500) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 03:20:28 GMT William Blair Maintains Larimar Therapeutics(LRMR.US) With Buy Rating - MoomooMoomoo · Wed, 05 Aug 2026 18:03:19 GMT LRMR Maintained by Wedbush -- Price Target Lowered to $11.00 - GuruFocusGuruFocus · Wed, 05 Aug 2026 16:02:20 GMT Larimar Therapeutics (LRMR) Advances Nomlabofusp Submission Amid Mixed Financial Signals - GuruFocusGuruFocus · Tue, 04 Aug 2026 16:43:18 GMT Larimar Therapeutics 2Q 2026: Net loss $32.8M, Diluted EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 11:21:01 GMT Larimar Therapeutics Reports Positive Longer-Term Nomlabofusp Data and Progress Toward Rolling BLA Submission for Friedreich’s Ataxia - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:15:00 GMT LRMR: Rolling BLA submission for nomlabofusp underway; cash runway into Q3 2027, but more funding needed - TradingViewTradingView · Tue, 04 Aug 2026 11:12:57 GMT Larimar Therapeutics (Nasdaq: LRMR) logs $62.4M loss and advances BLA - Stock TitanStock Titan · Tue, 04 Aug 2026 11:12:46 GMT

Timeline

Fri, 07 Aug 2026 03:20:28 GMTLRMR Feb 2027 7.500 call (LRMR270219C00007500) Stock Price, News, Quote & History - Yahoo! Finance Canada

Wed, 05 Aug 2026 18:03:19 GMTWilliam Blair Maintains Larimar Therapeutics(LRMR.US) With Buy Rating - Moomoo

Wed, 05 Aug 2026 16:02:20 GMTLRMR Maintained by Wedbush -- Price Target Lowered to $11.00 - GuruFocus

Tue, 04 Aug 2026 16:43:18 GMTLarimar Therapeutics (LRMR) Advances Nomlabofusp Submission Amid Mixed Financial Signals - GuruFocus

Tue, 04 Aug 2026 11:21:01 GMTLarimar Therapeutics 2Q 2026: Net loss $32.8M, Diluted EPS $(0.30) — 10-Q Summary - TradingView

Tue, 04 Aug 2026 11:15:00 GMTLarimar Therapeutics Reports Positive Longer-Term Nomlabofusp Data and Progress Toward Rolling BLA Submission for Friedreich’s Ataxia - Quiver Quantitative

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

LRMR Feb5 live mentions Larimar Therapeutics4 live mentions TradingView LRMR3 live mentions Yahoo Finance Singapore3 live mentions Stock Price2 live mentions Quote2 live mentions With Buy Rating2 live mentions Wedbush2 live mentions Price Target Lowered2 live mentions Advances Nomlabofusp Submission2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lrmr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.